{"a":[{"_":"Regeneron backs $75M series A for antibody upstart Infinimmune","$":{"href":"/biotech/regeneron-backs-75m-series-antibody-upstart-infinimmune","hreflang":"en"}}]}

Summary

Infinimmune secured a $75 million Series A funding round led by Regeneron's venture arm to advance its antibody discovery platform. The financing will support the company's research and development efforts.